National natural science foundation of China funding patterns and policy implications for obstetrics and gynecology research: a decade of trends (2011-2020).

IF 2.5 Q1 HEALTH POLICY & SERVICES
Journal of Pharmaceutical Policy and Practice Pub Date : 2025-08-27 eCollection Date: 2025-01-01 DOI:10.1080/20523211.2025.2547377
Dan Li, Xinyuan Chen, Yue Dong, Liwei Zou
{"title":"National natural science foundation of China funding patterns and policy implications for obstetrics and gynecology research: a decade of trends (2011-2020).","authors":"Dan Li, Xinyuan Chen, Yue Dong, Liwei Zou","doi":"10.1080/20523211.2025.2547377","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The National Natural Science Foundation of China (NSFC) plays a pivotal role in supporting basic medical research and shaping national funding priorities. As clinical and scientific demands in obstetrics and gynecology grow, particularly in areas closely tied to pharmacological interventions and maternal-fetal health, understanding funding patterns is essential for guiding research strategy and health policy. This study aimed to evaluate NSFC funding trends in obstetrics and gynecology from 2011 to 2020 and examine their alignment with research output and policy-relevant themes.</p><p><strong>Methods: </strong>Data from 2011 to 2020 were collected from official public sources. Descriptive analyses were conducted to assess funding trends by volume, project type, institutional and regional distribution, and research focus. SCI-indexed publication data were retrieved to evaluate the consistency between funding levels and high-impact scientific productivity.</p><p><strong>Results: </strong>NSFC funding in obstetrics and gynecology increased steadily over the decade, with a notable rise in support for early-career researchers through the Young Scientists Fund. Funding was geographically concentrated in eastern China, particularly in Beijing, Shanghai, and Guangzhou, with limited representation from central and western regions. Priority research themes included gestational diseases, reproductive health, and prenatal diagnostics. The average overlap between top-funded institutions and those with high SCI publication output was 61%, indicating only partial alignment between funding distribution and scientific productivity.</p><p><strong>Conclusions: </strong>While NSFC funding has played a critical role in advancing obstetrics and gynecology research in China, structural challenges persist. These include limited investment in high-tier and translational projects, regional disparities, and a mismatch between funding and publication output. The evolving focus of the NSFC on innovation and long-term impact over traditional publication metrics underscores the need for strategic reforms. Enhancing interdisciplinary integration, promoting equitable resource allocation, and adopting outcome-based evaluation frameworks are essential to better support pharmacological research and policy-driven improvements in maternal and reproductive health.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"18 1","pages":"2547377"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12392436/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20523211.2025.2547377","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The National Natural Science Foundation of China (NSFC) plays a pivotal role in supporting basic medical research and shaping national funding priorities. As clinical and scientific demands in obstetrics and gynecology grow, particularly in areas closely tied to pharmacological interventions and maternal-fetal health, understanding funding patterns is essential for guiding research strategy and health policy. This study aimed to evaluate NSFC funding trends in obstetrics and gynecology from 2011 to 2020 and examine their alignment with research output and policy-relevant themes.

Methods: Data from 2011 to 2020 were collected from official public sources. Descriptive analyses were conducted to assess funding trends by volume, project type, institutional and regional distribution, and research focus. SCI-indexed publication data were retrieved to evaluate the consistency between funding levels and high-impact scientific productivity.

Results: NSFC funding in obstetrics and gynecology increased steadily over the decade, with a notable rise in support for early-career researchers through the Young Scientists Fund. Funding was geographically concentrated in eastern China, particularly in Beijing, Shanghai, and Guangzhou, with limited representation from central and western regions. Priority research themes included gestational diseases, reproductive health, and prenatal diagnostics. The average overlap between top-funded institutions and those with high SCI publication output was 61%, indicating only partial alignment between funding distribution and scientific productivity.

Conclusions: While NSFC funding has played a critical role in advancing obstetrics and gynecology research in China, structural challenges persist. These include limited investment in high-tier and translational projects, regional disparities, and a mismatch between funding and publication output. The evolving focus of the NSFC on innovation and long-term impact over traditional publication metrics underscores the need for strategic reforms. Enhancing interdisciplinary integration, promoting equitable resource allocation, and adopting outcome-based evaluation frameworks are essential to better support pharmacological research and policy-driven improvements in maternal and reproductive health.

Abstract Image

Abstract Image

Abstract Image

中国国家自然科学基金资助模式及其对妇产科研究的政策影响:十年趋势(2011-2020)。
背景:中国国家自然科学基金委员会(NSFC)在支持基础医学研究和决定国家资助重点方面发挥着关键作用。随着妇产科临床和科学需求的增长,特别是在与药理干预和母胎健康密切相关的领域,了解资助模式对于指导研究战略和卫生政策至关重要。本研究旨在评估2011 - 2020年国家自然科学基金对妇产科的资助趋势,并考察其与研究产出和政策相关主题的一致性。方法:2011 - 2020年数据来源于官方公开来源。进行了描述性分析,以按数量、项目类型、机构和区域分布以及研究重点评估供资趋势。检索sci索引的出版物数据,以评估资助水平与高影响力科学生产力之间的一致性。结果:近十年来,国家自然科学基金对妇产科的资助稳步增加,通过青年科学家基金对早期职业研究人员的支持显著增加。资金在地理上主要集中在中国东部,特别是北京、上海和广州,中西部地区的代表有限。优先研究主题包括妊娠疾病、生殖健康和产前诊断。顶级科研机构与SCI发表量高的科研机构之间的平均重叠率为61%,表明科研经费分配与科研生产力之间只有部分重合。结论:虽然国家自然科学基金在推动中国妇产科研究方面发挥了关键作用,但结构性挑战依然存在。这些问题包括对高层次和转化项目的投资有限,地区差异,以及资金和出版产出之间的不匹配。国家自然科学基金委员会对创新和对传统出版指标的长期影响的不断发展的关注强调了战略改革的必要性。加强跨学科整合、促进公平的资源分配和采用基于结果的评估框架对于更好地支持药理学研究和政策驱动的孕产妇和生殖健康改进至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice Health Professions-Pharmacy
CiteScore
4.70
自引率
9.50%
发文量
81
审稿时长
14 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信